PMC:7247521 / 231-348 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7247521","sourcedb":"PMC","sourceid":"7247521","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7247521","text":"ia anti-viral, anti-inflammatory and metabolic programming.\n• 9 QFPD ingredients presented good molecular docking sc","divisions":[{"label":"label","span":{"begin":60,"end":61}}],"tracks":[{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T5","span":{"begin":8,"end":13},"obj":"NCBITaxon:10239"},{"id":"T6","span":{"begin":19,"end":32},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T7","span":{"begin":37,"end":46},"obj":"GO:0008152"},{"id":"T45473","span":{"begin":8,"end":13},"obj":"NCBITaxon:10239"},{"id":"T92290","span":{"begin":19,"end":32},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T26450","span":{"begin":37,"end":46},"obj":"GO:0008152"}],"attributes":[{"subj":"T5","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T6","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T7","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T45473","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T92290","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T26450","pred":"source","obj":"LitCovid-PMC-OGER-BB"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PMC-OGER-BB","color":"#a4ec93","default":true}]}]}}